Data availability
Novartis is committed to sharing access to patient-level data and supporting clinical documents from eligible clinical trials with qualified external researchers upon request. These requests are reviewed and approved by an independent review panel based on scientific merit. All data provided are anonymized to respect the privacy of patients who have participated in the trial consistent with applicable laws and regulations. The data sets generated during and/or analyzed during the current trial are available according to the criteria and process described on 